Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice

REFERENCES

• Adams, T. E., J. A. Hansen, R. Starr, N. A. Nicola, D. J. Hilton, and J. Billestrup 1998. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273:1285–1287.
   PubMedGoogle Scholar
• Bix, M., Z. E. Wang, B. Thiel, N. J. Schork, and J. Locksley 1998. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J. Exp. Med. 188:2289–2299.
   PubMed Web of Science ®Google Scholar
• Cella, N., B. Groner, and J. Hynes 1998. Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocorticoid receptor in mammary cells. Mol. Cell. Biol. 18:1783–1792.
   PubMedGoogle Scholar
• Darnell, J. E. Jr.. 1997. STATs and gene regulation. Science 277:1630–1635.
   PubMed Web of Science ®Google Scholar
• Durbin, J. E., R. Hackenmiller, M. C. Simon, and J. Levy 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443–450.
   PubMed Web of Science ®Google Scholar
• Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and J. Yoshimura 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924.
   PubMed Web of Science ®Google Scholar
• Feldman, G. M., L. A. Rosenthal, X. Liu, M. P. Hayes, A. Wynshaw-Boris, W. J. Leonard, L. Hennighausen, and J. Finbloom 1997. STAT5a deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90:1768–1776.
   PubMedGoogle Scholar
• Helman, D., Y. Sandowski, Y. Cohen, A. Matsumoto, A. Yoshimura, S. Merchav, and J. Gertler 1998. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling. FEBS Lett. 441:287–291.
   PubMedGoogle Scholar
• Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331–334.
   PubMed Web of Science ®Google Scholar
• Ikawa, M., S. Yamada, T. Nakanishi, and J. Okabe 1999. Green fluorescent protein (GFP) as a vital marker in mammals. Curr. Top. Dev. Biol. 44:1–20.
   PubMedGoogle Scholar
• Imada, K., E. T. Bloom, H. Nakajima, J. A. Horvath-Arcidiacono, G. B. Udy, H. W. Davey, and J. Leonard 1998. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 188:2067–2074.
   PubMed Web of Science ®Google Scholar
• Jiao, H., K. Berrada, W. Yang, M. Tabrizi, L. C. Platanias, and J. Yi 1996. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16:6985–6992.
   PubMed Web of Science ®Google Scholar
• Kaplan, M. H., Y.-L. Sun, T. Hoey, and J. Grusby 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174–177.
   PubMed Web of Science ®Google Scholar
• Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and J. Lodish 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729–738.
   PubMed Web of Science ®Google Scholar
• Kubo, M., J. Ransom, D. Webb, Y. Hashimoto, T. Tada, and J. Nakayama 1997. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J. 16:4007–4020.
   PubMed Web of Science ®Google Scholar
• Liu, X., G. W. Robinson, and J. Hennighausen 1996. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol. 10:1496–1506.
   PubMedGoogle Scholar
• Liu, X., G. W. Robinson, K.-U. Wagner, L. Garrett, A. Wynshaw-Boris, and J. Hennighausen 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179–186.
   PubMed Web of Science ®Google Scholar
• Masuhara, M., H. Sakamoto, A. Matsumoto, R. Suzuki, H. Yasukawa, K. Mitsui, T. Wakioka, S. Tanimura, A. Sasaki, H. Misawa, M. Yokouchi, M. Ohtsubo, and J. Yoshimura 1997. Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239:439–446.
   PubMedGoogle Scholar
• Matsumoto, A., M. Masuhara, K. Mitsui, M. Yokouchi, M. Ohtsubo, H. Misawa, A. Miyajima, and J. Yoshimura 1997. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89:3148–3154.
   PubMed Web of Science ®Google Scholar
• Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and J. Schreiber 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431–442.
   PubMed Web of Science ®Google Scholar
• Moriggl, R., D. J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M. Y. Sangster, K. D. Bunting, G. C. Grosveld, and J. Ihle 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249–259.
   PubMedGoogle Scholar
• Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and J. Kishimoto 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–929.
   PubMed Web of Science ®Google Scholar
• Nakajima, H., X.-W. Liu, A. Wynshaw-Boris, L. A. Rosenthal, K. Imada, D. S. Finbloom, L. Hennighausen, and J. Leonard 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity 7:691–701.
   PubMed Web of Science ®Google Scholar
• Niwa, H., K. Yamamura, and J. Miyazaki 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–199.
   PubMed Web of Science ®Google Scholar
• Norstedt, G., and J. Palmiter 1984. Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell 36:805–812.
   PubMedGoogle Scholar
• O’Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7:1–11.
   PubMedGoogle Scholar
• Ripperger, J. A., S. Fritz, K. Richter, G. M. Hocke, F. Lottspeich, and J. Fey 1995. Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin-6 response elements. J. Biol. Chem. 270:29998–30006.
   PubMedGoogle Scholar
• Sakamoto, H., H. Yasukawa, M. Masuhara, S. Tanimura, A. Sasaki, K. Yuge, M. Ohtsubo, S. Ohtsuka, T. Fujita, T. Ohta, Y. Furukawa, S. Iwase, H. Yamada, and J. Yoshimura 1998. A Janus kinase inhibitor, JAB, is an interferon-γ inducible gene and confers resistance to interferons. Blood 92:1668–1676.
   PubMed Web of Science ®Google Scholar
• Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. Ihle 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630–633.
   PubMed Web of Science ®Google Scholar
• Shultz, L. D., P. A. Schweitzer, T. V. Rajan, T. Yi, J. N. Ihle, R. J. Matthews, M. L. Thomas, and J. Beier 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445–1454.
   PubMed Web of Science ®Google Scholar
• Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and J. Hilton 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917–921.
   PubMed Web of Science ®Google Scholar
• Suzuki, R., H. Sakamoto, H. Yasukawa, M. Masuhara, T. Wakioka, A. Sasaki, K. Yuge, S. Komiya, A. Inoue, and J. Yoshimura 1998. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene 17:2271–2278.
   PubMed Web of Science ®Google Scholar
• Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and J. Akira 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627–630.
   PubMed Web of Science ®Google Scholar
• Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and J. Akira 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94:3801–3804.
   PubMed Web of Science ®Google Scholar
• Teglund, S., C. McKay, E. Schuetz, J. M. van Deursen, D. Straopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. Ihle 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841–852.
   PubMed Web of Science ®Google Scholar
• Udy, G. B., R. P. Towers, R. G. Snell, R. J. Wilkins, S.-H. Park, P. A. Ram, D. J. Waxman, and J. Davey 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94:7239–7242.
   PubMed Web of Science ®Google Scholar
• Verdier, F., S. Chretien, O. Muller, P. Varlet, A. Yoshimura, S. Gisselbrecht, C. Lacombe, and J. Mayeux 1998. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated CIS protein. J. Biol. Chem. 273:28185–28190.
   PubMed Web of Science ®Google Scholar
• Welte, T., D. Leitenberg, B. N. Dittel, B. K. al-Ramadi, B. Xie, Y. E. Chin, C. A. Janeway Jr., A. L. M. Bothwell, K. Bottomly, and J. Fu 1999. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283:222–225.
   PubMed Web of Science ®Google Scholar
• Yamashita, M., K. Hashimoto, M. Kimura, M. Kubo, and J. Nakayama 1998. Requirement for p56 (lck) tyrosine kinase activation in Th subset differentiation. Int. Immunol. 10:577–591.
   PubMedGoogle Scholar
• Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, A. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and J. Yoshimura 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309–1320.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A., T. Ohkubo, T. Kiguchi, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, T. Hara, and J. Miyajima 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:2816–2826.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A., M. Ichihara, I. Kinjyo, M. Moriyama, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, T. Hara, and J. Miyajima 1996. Mouse oncostatin M: an immediate early response gene induced by multiple cytokines through the JAKs/STAT5 pathway. EMBO J. 15:1055–1063.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A. 1998. The CIS/JAB family: novel negative regulators of JAK signaling pathways. Leukemia 12:1851–1857.
   PubMed Web of Science ®Google Scholar